Pacific Biosciences of California, Inc. logo PACB - Pacific Biosciences of California, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 8
SELL 1
STRONG
SELL
0
| PRICE TARGET: $1.00 DETAILS
HIGH: $1.00
LOW: $1.00
MEDIAN: $1.00
CONSENSUS: $1.00
DOWNSIDE: 33.99%

About Pacific Biosciences of California, Inc. (https://www.pacb.com)

Pacific Biosciences of California, Inc. (PACB) specializes in pioneering and manufacturing advanced genetic sequencing platforms, empowering researchers and institutions to unravel intricate genetic challenges. At the heart of its offerings are the proprietary PacBio Sequencing Systems, designed for executing, monitoring, and interpreting biochemical sequencing reactions. Complementing these instruments are essential consumable products, such as their unique single molecule real-time (SMRT) cells. Furthermore, the company supplies a comprehensive suite of workflow-specific reagent kits. These include template preparation kits, which utilize molecular biology reagents (like ligase, buffers, and exonucleases) to convert DNA into SMRTbell double-stranded DNA libraries. Binding kits, featuring modified DNA polymerase, facilitate the crucial attachment of SMRTbell libraries to the polymerase in readiness for sequencing. Finally, specialized sequencing kits contain all necessary reagents, including phospholinked nucleotides, for real-time sequencing directly on their instruments. Pacific Biosciences caters to a broad global clientele, encompassing prominent research institutions, commercial diagnostic laboratories, large-scale genome centers, public health organizations, hospitals, clinical research institutes, contract research organizations (CROs), academic bodies, pharmaceutical firms, and agricultural enterprises. Product commercialization is managed through a direct sales force across North America and Europe, complemented by a robust network of distribution partners spanning Asia, the Middle East, Africa, and Latin America. A significant strategic alliance includes a development and commercialization agreement with Invitae Corporation. Originally incorporated in 2000 as Nanofluidics, Inc., the company adopted its current name, Pacific Biosciences of California, Inc., in 2005. Its corporate headquarters are situated in Menlo Park, California.

Key Executives

NAME TITLE DOB SALARY
Christian O. Henry President, Chief Executive Officer & Director 1968 $1,462,555 USD
Mark Van Oene Chief Operating Officer 1973 $977,190 USD
James R. Gibson CFO & Principal Accounting Officer 1970 $700,506 USD
Stephen Turner Co-Founder 1968 $341,250 USD
Brett Atkins General Counsel & Corporate Secretary
Natalie Welch Chief People Officer

Company Peers

Peer analysis pending, check back in 1-2 minutes.